background

News

行動基因聲明稿

2023-06-01

行動基因聲明稿

有關多家媒體於5月31日報導「中資透過股權併購方式買下行動基因，建構中的癌症基因資料庫也一併落入中資手中，造成台灣人基因資訊外洩」，與事實不符。為避免被惡意抹黑，以訛傳訛，同時嚴重影響本公司聲譽及業務經營，特予澄清。

Location: Taiwan
Prenetics Owned ACT Genomics Receives FDA Clearance for ACTOnco, the First Asia-Based Company to Receive Clearance for a Comprehensive Genomic Profiling Test for All Solid Tumors

2023-01-10

Prenetics Owned ACT Genomics Receives FDA Clearance for ACTOnco, the First Asia-Based Company to Receive Clearance for a Comprehensive Genomic Profiling Test for All Solid Tumors

• Prenetics has completed the majority stake acquisition of ACT Genomics to spearhead its entry into to the US$80+ billion global precision oncology market • FDA market authorization advances personalized cancer care in Asia • Clearance sets the stage for continued R&D investment into early detection / liquid biopsy

Location: Taiwan
關於Prenetics 收購行動基因的分享及說明

2022-12-16

關於Prenetics 收購行動基因的分享及說明

Location: Taiwan
Advanced Precision Cancer Medicine Forum will be held on Aprl 17

2022-04-11

Advanced Precision Cancer Medicine Forum will be held on April 17

New medical technologies have been advancing more rapidly than ever, including the application of precision medicine and artificial intelligence in cancer clinical treatment planning and biomarkers discovery. Hosted by Taiwan Oncology Society, ACT Genomics co-organizes the Advanced Precision Cancer Medicine Forum (APCM) and we have invited experts in specific areas to share their first-hand experiences about the latest developments and phenomena in cancer management and valuable insights on the best strategy moving forward.

Location: Taiwan
Sparing a thought in the epidemic to tide over the difficulties: ACT Genomics & Sanomics together with Novartis are to provide free liquid based lung cancer panels for cancer patients in Hong Kong

2022-04-06

ACT Genomics & Sanomics cooperate with Novartis to provide free liquid based lung cancer panels for cancer patients

The new corona virus has almost paralyzed the public medical system. Lung cancer patients who originally receive treatments in public hospitals will be affected and some of them have to turn to private doctors for treatments. In order to allow patients to grasp the golden treatment period, ACT Genomics and Novartis will provide free blood based diagnostic testing for 3 months to lung cancer patients seeking medical treatments in the private sector.

Location: Hong Kong
Online Gallery｜Where there is action, hope will glow. Let’s all make a promise under the rainbow.

2022-02-09

Hope and Rainbows

This year, we invited Abu, an illustrator as well as a cancer fighter, together with the Nurse Educator team in Taiwan, to create a few new paintings which heartily reflect the sensation of fragility and strength, pain and joy as well as inner conflict and relief while fighting against cancer. With these paintings from Abu and the life stories of the patients, we will launch a series of events with the title “Hope and Rainbows” at the end of 2021.

Location: Taiwan